Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

October 12, 2022 07:30 ET | Source: Assertio Holdings, Inc.

Assertio to Participate in October 2022 Investor Conferences

LAKE FOREST, Ill., Oct. 12, 2022 (GLOBE NEWSWIRE) -- Assertio Holdings, Inc. ("Assertio" or the "Company") (Nasdaq: ASRT), a specialty pharmaceutical company offering differentiated products to...
September 07, 2022 09:00 ET | Source: Assertio Holdings, Inc.

Assertio to Participate in the 2022 Lake Street BIG6 Conference

LAKE FOREST, Ill., Sept. 07, 2022 (GLOBE NEWSWIRE) -- Assertio Holdings, Inc. ("Assertio" or the "Company") (Nasdaq: ASRT), a specialty pharmaceutical company offering differentiated products to...
August 25, 2022 10:24 ET | Source: Assertio Holdings, Inc.

Assertio Announces Closing of $70 Million Convertible Senior Notes Offering

LAKE FOREST, Ill., Aug. 25, 2022 (GLOBE NEWSWIRE) -- Assertio Holdings, Inc. ("Assertio" or the "Company") (Nasdaq: ASRT), a specialty pharmaceutical company offering differentiated products to...
August 22, 2022 22:06 ET | Source: Assertio Holdings, Inc.

Assertio Prices $60 Million Convertible Senior Notes Offering to Refinance Existing 13% Senior Secured Notes Due 2024

LAKE FOREST, Ill., Aug. 22, 2022 (GLOBE NEWSWIRE) -- Assertio Holdings, Inc. (“Assertio” or the “Company”) (Nasdaq: ASRT), a specialty pharmaceutical company offering differentiated products to...
August 22, 2022 16:01 ET | Source: Assertio Holdings, Inc.

Assertio Announces Proposed Convertible Senior Notes Offering to Refinance Existing 13% Senior Secured Notes Due 2024

LAKE FOREST, Ill., Aug. 22, 2022 (GLOBE NEWSWIRE) -- Assertio Holdings, Inc. (“Assertio” or the “Company”) (Nasdaq: ASRT), a specialty pharmaceutical company offering differentiated products to...
August 08, 2022 07:00 ET | Source: Assertio Holdings, Inc.

Assertio Reports Second Quarter 2022 Financial Results

Net Product Sales Increase 40% Year-Over-Year, Non-GAAP Adjusted EBITDA Increases to $22.9 million Raises Full Year Revenue and Non-GAAP Adjusted EBITDA Guidance LAKE FOREST, Ill., Aug. 08, 2022 ...
July 25, 2022 08:30 ET | Source: Assertio Holdings, Inc.

Assertio Holdings, Inc. To Report Second Quarter 2022 Financial Results on Monday, August 8, 2022

LAKE FOREST, Ill., July 25, 2022 (GLOBE NEWSWIRE) -- Assertio Holdings, Inc. (“Assertio” or the “Company”) (Nasdaq: ASRT), a specialty pharmaceutical company offering differentiated products to...
July 12, 2022 18:47 ET | Source: Assertio Holdings, Inc.

Assertio Holdings, Inc. Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

LAKE FOREST, Ill., July 12, 2022 (GLOBE NEWSWIRE) -- Assertio Holdings, Inc. (“Assertio” or the “Company”) (NASDAQ: ASRT), a specialty pharmaceutical company offering differentiated products to...
June 01, 2022 08:30 ET | Source: Assertio Holdings, Inc.

Assertio Holdings, Inc. to Participate in LD Micro Invitational XII Conference

LAKE FOREST, Ill., June 01, 2022 (GLOBE NEWSWIRE) -- Assertio Holdings, Inc. (“Assertio” or the “Company”) (NASDAQ: ASRT), a specialty pharmaceutical company offering differentiated products to...
May 09, 2022 16:01 ET | Source: Assertio Holdings, Inc.

Assertio Reports First Quarter 2022 Financial Results

Reaffirms Full Year Net Product Sales and Raises Full Year Non-GAAP Adjusted EBITDA Guidance Net Product Sales Up 37% and Non-GAAP Adjusted EBITDA Up 52% Compared to Prior Year Quarter Quarterly...